UNC Charlotte-Led Team Invents New Anticoagulant Platform, Offering Hope For Advances For Heart Surgery, Dialysis, Other Procedures
A new biomolecular anticoagulant platform invented by a team led by UNC Charlotte researcher Kirill Afonin holds promise as a revolutionary advancement over the blood thinners currently used during surgeries and other procedures. While blood clotting is important to prevent blood loss and for our immunity, coagulation also can cause health issues and even death. Anticoagulants used to reduce risks can also cause significant issues, such as uncontrolled bleeding.